日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Discovery of Axelopran (TD-1211): A Peripherally Restricted μ-Opioid Receptor Antagonist

Axelopran (TD-1211) 的发现:一种外周限制性 μ-阿片受体拮抗剂

Long, Daniel D; Armstrong, Scott R; Beattie, David T; Campbell, Christina B; Church, Timothy J; Colson, Pierre-Jean; Dalziel, Sean M; Jacobsen, John R; Jiang, Lan; Obedencio, Glenmar P; Rapta, Miroslav; Saito, Daisuke; Stergiades, Ioanna; Tsuruda, Pamela R; Van Dyke, Priscilla M; Vickery, Ross G

Development and binding mode assessment of N-[4-[2-propyn-1-yl[(6S)-4,6,7,8-tetrahydro-2-(hydroxymethyl)-4-oxo-3H-cyclopenta[g]quinazolin-6-yl]amino]benzoyl]-l-γ-glutamyl-D-glutamic acid (BGC 945), a novel thymidylate synthase inhibitor that targets tumor cells.

对靶向肿瘤细胞的新型胸苷酸合成酶抑制剂 N-[4-[2-丙炔-1-基[(6S)-4,6,7,8-四氢-2-(羟甲基)-4-氧代-3H-环戊并[g]喹唑啉-6-基]氨基]苯甲酰基]-l-γ-谷氨酰-D-谷氨酸 (BGC 945) 进行开发和结合模式评估

Tochowicz Anna, Dalziel Sean, Eidam Oliv, O'Connell Joseph D 3rd, Griner Sarah, Finer-Moore Janet S, Stroud Robert M